Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

Lipoprotein(a) and Coronary Heart Disease: A Meta-Analysis of Prospective Studies
Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study
Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men
Update in lipid alterations in subclinical hypothyroidism
Hypothyroidism and dyslipidemia: modern concepts and approaches
Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia
Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy
Effects of subclinical hypothyroidism and its treatment on serum lipids
Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease
CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections
LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction
LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction
Expanding role of gut microbiota in lipid metabolism
Pathophysiological role of host microbiota in the development of obesity
Mercury and metabolic syndrome: a review of experimental and clinical observations
Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease?
Potential sources of phthalates and bisphenol A and their significance in the development of metabolic diseases
Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits
Metabolic comorbidities in Cushing’s syndrome
Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing’s syndrome
The straight dope on cholesterol – Part V
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men
Relationship Between the Apolipoprotein E Genotype and LDL Particle Size in Patients With Obstructive Sleep Apnea
Familial Hypercholesterolemia
Mechanisms of disease: genetic causes of familial hypercholesterolemia
Nonpharmacologic treatment of dyslipidemia
The role of nutraceutical supplements in the treatment of dyslipidemia
Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial
Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
Nonpharmacologic treatment of dyslipidemia
The role of nutraceutical supplements in the treatment of dyslipidemia
Low Serum Glutathione Peroxidase Activity Is Associated with Increased Cardiovascular Mortality in Individuals with Low HDLc’s
Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities
Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease
Antioxidant Enzyme Activity and Coronary Heart Disease: Meta-analyses of Observational Studies
Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice
Could dyslipidemic children benefit from glucomannan intake?
A Combination Therapy Including Psyllium and Plant Sterols Lowers LDL Cholesterol by Modifying Lipoprotein Metabolism in Hypercholesterolemic Individuals
Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)